MSLE
Satellos Bioscience, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · CA
$9.32
−3.72%Institutional positioning
13F filings over the trailing two quarters
New 33Increased 6Reduced 6Sold out 7
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FRANKLIN RESOURCES INC | New Position | 938,666 | May 13, 2026 |
| FRANKLIN RESOURCES INC | Unchanged | 938,666 | Aug 13, 2026 |
| SIREN, L.L.C. | New Position | 892,074 | May 14, 2026 |
| Siren, L.L.C. | Unchanged | 892,074 | Aug 13, 2026 |
| Vivo Capital, LLC | Unchanged | 813,666 | Aug 14, 2026 |
| VIVO CAPITAL, LLC | New Position | 813,666 | May 20, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | New Position | 690,778 | May 15, 2026 |
| Point72 Asset Management, L.P. | Reduced | 682,700 | Aug 14, 2026 |
| SPHERA FUNDS MANAGEMENT LTD. | Increased | 652,590 | Aug 14, 2026 |
| WOODLINE PARTNERS LP | New Position | 500,432 | May 15, 2026 |
| Woodline Partners LP | Unchanged | 500,432 | Aug 14, 2026 |
| Stonepine Capital Management, LLC | Increased | 491,624 | Aug 17, 2026 |
| SPHERA FUNDS MANAGEMENT LTD. | New Position | 489,207 | May 15, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Unchanged | 475,000 | Aug 14, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | New Position | 475,000 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings